https://www.wired.com/story/alzheimers-drugs-benefits-risks-lecanemab-donanemab/
0
0
5/24/23 at 11:00am
Organization
Wired
Author
Grace Huckins
30 words
0
Comments
Antibody treatments clear amyloid protein from patients' brains, slowing the progression of their disease but potentially inducing deadly swelling.
You are the first to view
Create an account
or login to join the discussion